trial

Comparaison of Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia With Treatment Refractory Hallucinations

NCTId NCT04054778
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 136 (estimated)
Sponsored by Ciusss de L'Est de l'Île de Montréal
Primary completion 2025-04-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
136 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2019-04-01
Primary completion
2025-04-01
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Avatar therapyCognitive Behavioral Therapy

Sponsors

Ciusss de L'Est de l'Île de MontréalLead Sponsor
Canadian Institutes of Health Research (CIHR)Collaborator

Investigators

1
Alexandre Dumais, MD, PhDPrincipal Investigator

Sites

1 total
Montreal, Canada

Facts & assertions

4 sourced
Enrollment
136
Phase
NA
Primary Completion Date
2025-04-01
Status
UNKNOWN
relationships
The graph out of here
drug
Avatar therapy
drug
Cognitive Behavioral Therapy
drug
lead_sponsor
Ciusss de L'Est de l'Île de Montréal
company
collaborator
Canadian Institutes of Health Research (CIHR)
company
indication
Hallucinations
indication
Treatment-resistant Schizophrenia
indication
Auditory Hallucination, Verbal
indication
investigator
Alexandre Dumais, MD, PhD
person